Are You Prepared for the New Wave of ADCs in NSCLC? Targeting HER2, HER3, TROP2, and Others PeerView Oncology 56:23 1 year ago 5 172 Скачать Далее
Answers to Key Questions About Antibody–Drug Conjugates in NSCLC PeerView Oncology 1:00:29 1 year ago 460 Скачать Далее
Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC to Address Unmet Needs PeerView Oncology 48:40 7 months ago 254 Скачать Далее
Amplifying the ADC Advantage: ADCs as the Next Frontier in Precision Lung Cancer Care PeerView Oncology 1:37:33 11 months ago 1 619 Скачать Далее
New Hope in Cancer Treatment! What are Antibody-Drug Conjugates (ADCs) Dr. Constantine 7:06 8 months ago 95 Скачать Далее
Is ADC the answer to lung cancer #2023 #oncology #lungcancer OncBrothers: Practice-Changing Cancer Discussions 0:59 9 months ago 1 789 Скачать Далее
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference Total Health | Oncology 27:03 1 year ago 11 058 Скачать Далее
Exploring antibody-drug conjugates (ADCs) in lung cancer VJOncology 2:26 1 year ago 151 Скачать Далее
Targeting EGFR-positive NSCLC with antibody-drug conjugates VJOncology 1:25 1 year ago 129 Скачать Далее
2021 West Oncology | Lung Cancer | EGFR Mutation Therapy Resistance and ADCs and TROP2 Total Health | Oncology 20:34 3 years ago 2 073 Скачать Далее
The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer CME Outfitters 1:26:11 3 years ago 332 Скачать Далее
Improving Patient Outcomes in Urothelial Carcinoma With Novel Antibody–Drug Conjugates PeerView Oncology 40:12 1 year ago 152 Скачать Далее
